Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
AbbVie NYSE:ABBV |
406,87 B | 2,49% | 4/6 | 25,35% | -54,40% | 8,64% | UP |
|
Amgen NasdaqGS:AMGN |
199,20 B | 7,37% | 3/6 | 2,70% | -13,99% | -4,88% | UP |
|
Gilead Sciences NasdaqGS:GILD |
178,72 B | 3,30% | 5/6 | 4,64% | -58,71% | 11,14% | UP |
|
Alnylam Pharmaceuticals NasdaqGS:ALNY |
42,53 B | 46,06% | 4/6 | 50,26% | 0,70% | 40,65% | DOWN |
|
Alexion Pharmaceuticals NasdaqGM:ALXN |
40,34 B | 0,00% | 4/4 | 0,00% | 0,00% | -100,00% | UP |
|
Biogen NasdaqGS:BIIB |
27,13 B | -10,57% | 1/6 | -1,11% | 8,47% | 11,70% | UP |
|
Incyte NasdaqGS:INCY |
19,09 B | 41,79% | 6/6 | 9,03% | 26,54% | 14,65% | UP |
|
BioMarin Pharmaceutical NasdaqGS:BMRN |
11,76 B | 12,22% | 5/6 | 45,49% | 53,83% | 53,80% | UP |
|
Blueprint Medicines NasdaqGS:BPMC |
8,38 B | 45,26% | 4/6 | 42,18% | -48,48% | 0,64% | UP |
|
Cidara Therapeutics NasdaqCM:CDTX |
6,97 B | -59,17% | 2/6 | 0,00% | -652349,57% | -100,00% | UP |
|
Arena Pharmaceuticals NasdaqGM:ARNA |
6,17 B | 0,00% | 0,00% | 0,00% | 0,00% | UP | |
|
Amicus Therapeutics NasdaqGM:FOLD |
4,50 B | 19,97% | 5/6 | 19,52% | -22,35% | 1,12% | UP |
|
ACADIA Pharmaceuticals NasdaqGS:ACAD |
3,78 B | 29,02% | 5/6 | 13,70% | 30,09% | 46,66% | DOWN |
|
ChemoCentryx NasdaqGS:CCXI |
3,74 B | 0,00% | 0/4 | 0,00% | 0,00% | -100,00% | UP |
|
ADMA Biologics NasdaqGM:ADMA |
3,67 B | 45,53% | 5/6 | 33,13% | -90,27% | 94,93% | DOWN |
|
CymaBay Therapeutics NasdaqGS:CBAY |
3,72 B | 0,00% | 1/4 | 0,00% | 0,00% | -100,00% | UP |
|
Viking Therapeutics NasdaqCM:VKTX |
3,81 B | 0,00% | 0/4 | 0,00% | 0,00% | 201,70% | DOWN |
|
Dicerna Pharmaceuticals NasdaqGM:DRNA |
2,99 B | 0,00% | 3/4 | 0,00% | 0,00% | -100,00% | UP |
|
Catalyst Pharmaceuticals NasdaqCM:CPRX |
2,96 B | 40,93% | 5/6 | 5,37% | 24,15% | 44,39% | UP |
|
Travere Therapeutics NasdaqGM:TVTX |
2,51 B | 10,07% | 5/6 | 43,61% | -41,14% | 57,86% | UP |
